[The use of a new bronchodynamic drug by aerosol administration in asthmatic bronchitis and emphysema patients. Study of the respiratory function].
D000336:Aerosols; D001249:Asthma / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D006801:Humans; D008170:Lung Compliance; D009921:Metaproterenol / Q000627:therapeutic use; D010627:Phenethylamines / Q000627:therapeutic use*; D011656:Pulmonary Emphysema / Q000188:drug therapy*; D012118:Resorcinols / Q000627:therapeutic use*; D013147:Spirometry; D014692:Ventilation-Perfusion Ratio
D000336:Aerosols; D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol
Impiego di un nuovo preparato broncodinamico per via aerosolica in soggetti bronchitici asmatici ed enfisematosi. Studio funzionale respiratio.